Twist Bioscience Corp
TWST
NASDAQ
Biotechnology
$118.57
USD
-6.72 (-5.36%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $8.23B
Volume 1.1M
Revenue
$409.48M
TTM
+17.8%
YoY
Gross Margin
52%
TTM
+11.5%
YoY
Net Income
$-81.28M
TTM
+57.5%
YoY
Operating Cash Flow
$-55.59M
TTM
+0.9%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 92.8 | 96.1 | 99.0 | 103.7 | 110.7 |
YoY Growth | +23.2% | +17.9% | +16.9% | +16.9% | +19.3% |
Cost of Revenue | 46.8 | 44.8 | 48.2 | 49.7 | 53.6 |
Gross Profit | 46.0 | 51.3 | 50.8 | 54.0 | 57.1 |
Selling, General & Administrative | 63.7 | 63.4 | 63.8 | 69.7 | 76.1 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 7.2 |
Total Operating Expenses | 87.6 | 81.4 | 80.8 | 86.9 | 103.0 |
Operating Income | -41.6 | -30.1 | -29.9 | -32.9 | -45.9 |
EBITDA | -35.2 | -24.1 | -23.9 | -26.7 | -32.2 |
Other Income / Expense | -0.4 | 48.0 | 0.4 | 0.5 | 0.2 |
Total Other Income / Expense | 2.4 | 50.7 | 3.1 | 2.6 | 1.9 |
Income Before Income Taxes | -39.2 | 20.6 | -26.9 | -30.3 | -44.0 |
Income Taxes | 0.2 | 0.2 | 0.3 | 0.3 | 0.0 |
Net Income | -39.3 | 20.4 | -27.1 | -30.5 | -44.0 |
Consolidated Net Income / Loss | -39.3 | 20.4 | -27.1 | -30.5 | -44.0 |
Net Income Attributable to Common Shareholders | -39.3 | 20.4 | -27.1 | -30.5 | -44.0 |
Basic EPS | -$0.66 | $0.34 | -$0.45 | -$0.50 | -$0.71 |
Diluted EPS | -$0.66 | $0.33 | -$0.46 | -$0.50 | -$0.71 |
Basic Shares Outstanding | 59.6M | 60.0M | 60.4M | 61.1M | 61.7M |
Diluted Shares Outstanding | 59.6M | 61.2M | 59.3M | 61.1M | 61.7M |